1. Home
  2. ATRA vs ABVE Comparison

ATRA vs ABVE Comparison

Compare ATRA & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • ABVE
  • Stock Information
  • Founded
  • ATRA 2012
  • ABVE 2019
  • Country
  • ATRA United States
  • ABVE Canada
  • Employees
  • ATRA N/A
  • ABVE N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • ABVE Packaged Foods
  • Sector
  • ATRA Health Care
  • ABVE Consumer Staples
  • Exchange
  • ATRA Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • ATRA 97.0M
  • ABVE 90.1M
  • IPO Year
  • ATRA 2014
  • ABVE N/A
  • Fundamental
  • Price
  • ATRA $14.41
  • ABVE $2.93
  • Analyst Decision
  • ATRA Strong Buy
  • ABVE
  • Analyst Count
  • ATRA 3
  • ABVE 0
  • Target Price
  • ATRA $21.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • ATRA 52.1K
  • ABVE 2.9M
  • Earning Date
  • ATRA 11-11-2025
  • ABVE 01-01-0001
  • Dividend Yield
  • ATRA N/A
  • ABVE N/A
  • EPS Growth
  • ATRA N/A
  • ABVE N/A
  • EPS
  • ATRA 0.56
  • ABVE N/A
  • Revenue
  • ATRA $188,667,000.00
  • ABVE $213,446,206.00
  • Revenue This Year
  • ATRA N/A
  • ABVE N/A
  • Revenue Next Year
  • ATRA N/A
  • ABVE N/A
  • P/E Ratio
  • ATRA $25.58
  • ABVE N/A
  • Revenue Growth
  • ATRA 202.41
  • ABVE N/A
  • 52 Week Low
  • ATRA $5.01
  • ABVE $0.25
  • 52 Week High
  • ATRA $18.71
  • ABVE $4.40
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 68.37
  • ABVE 75.70
  • Support Level
  • ATRA $13.12
  • ABVE $1.56
  • Resistance Level
  • ATRA $14.78
  • ABVE $1.99
  • Average True Range (ATR)
  • ATRA 0.84
  • ABVE 0.24
  • MACD
  • ATRA 0.16
  • ABVE 0.13
  • Stochastic Oscillator
  • ATRA 86.14
  • ABVE 96.71

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: